Three faculty members from the University of Maryland School of Pharmacy’s Center for Translational Medicine (CTM) will be part of an ambitious research collaboration that aims to create an artificial, shelf-stable blood product.
This research endeavor is federally funded by a $46.4 million four-year grant from the Defense Advanced Research Projects Agency (DARPA) and led by the University of Maryland School of Medicine (UMSOM). A synthetic blood product could potentially save thousands of lives, with applications including soldiers bleeding out in active war zones and trauma victims in remote locations.
Read the full story on the School of Pharmacy News Center.